"In these OAC-naive patients, asundexian was associated with a slight increase in stroke rates but demonstrated a lower risk ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

BMS is a longstanding player in cardiovascular with drugs like Pfizer-partnered Eliquis (apixaban ... which are both based on novel mechanisms of action – have been keenly anticipated by ...

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration to manufacture and market ...

Aurobindo Pharma Ltd has received final approval from the United States Food & Drug Administration (USFDA) to make and sell Rivaroxaban Tablets USP, 2.5mg — the generic equivalent of Janssen ...